Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

5M ago

BOLT

PremiumPress Releases

Bolt Biotherapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update

6M ago

BOLT

PremiumPress Releases

Bolt Biotherapeutics Presents Updated Clinical Data from Phase 1 Dose-Escalation Trial of BDC-1001 as Monotherapy and in Combination with Nivolumab in HER2-Expressing Tumors at ESMO 2023 Congress

7M ago

BOLT

PremiumPress Releases

Bolt Biotherapeutics Announces First Patient Dosed in Phase 1/2 Study of BDC-3042 in Patients with Advanced Cancers

7M ago

BOLT

PremiumPress Releases

Bolt Biotherapeutics to Present New Clinical Data from Completed Phase 1/2 Dose-Escalation Trial of BDC-1001 in HER2-Expressing Solid Tumors at the ESMO Congress 2023

7M ago

BOLT

More BOLT News >

BOLT News on the Web

2024-04-29

Is Bolt Biotherapeutics In A Good Position To Deliver On Growth Plans?

Yahoo Finance

Neutral

2024-03-22

BOLT Stock Earnings: Bolt Biotherapeutics Beats EPS, Beats Revenue for Q4 2023

InvestorPlace

Neutral

2024-03-21

Bolt Biotherapeutics Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

Yahoo Finance

Neutral

2024-02-27

Bolt Biotherapeutics to Present at the TD Cowen 44th Annual Healthcare Conference

Yahoo Finance

Neutral

2023-12-05

Bolt Biotherapeutics’ BDC-1001: A Promising Future in Oncology Drives Buy Rating

TipRanks News

Bullish

2023-12-05

Bolt Biotherapeutics Enrolls First Patient in Phase 2 Clinical Study Evaluating BDC-1001 in Patients with HER2-Positive Breast Cancer Previously Treated with Enhertu®

Yahoo Finance

Bullish

2023-11-20

Is Bolt Biotherapeutics In A Good Position To Invest In Growth?

Yahoo Finance

Neutral

2023-11-14

Analysts Offer Insights on Healthcare Companies: AN2 Therapeutics, Inc. (ANTX), Pliant Therapeutics (PLRX) and Bolt Biotherapeutics (BOLT)

TipRanks News

Bullish

News Score - Last 7 Days

Neutral

BOLT

Sector Average

Media Buzz

This Week1 articles

Weekly Average1 articles

News Sentiment

This Week50%

Sector Average58%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is BOLT’s Media Buzz Sentiment?

1 articles about BOLT were published this week. In an average week, 1 articles are published.

What is BOLT’s weekly average amount of articles?

In an average week, 1 articles about BOLT are published.

What is BOLT’s News Sentiment?

50% of articles about BOLT were positive this week, compared to its sector average of 58%.

Healthcare Stocks that are Trending in the News

OXBDFOxford BioMedica

RMDResmed

THCTenet Healthcare

CNCCentene

TECHBio-Techne

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing